Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904553 · ClinicalTrials.gov registry record
Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
A clinical trial of Neoplasm Metastasis, sponsored by University of Rochester.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT00904553 is a study of Neoplasm Metastasis that has completed, run by University of Rochester. The registered enrollment target is 25 participants, below the 415-participant average among 41 other Neoplasm Metastasis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00904553, a study of Neoplasm Metastasis, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to look more closely at the tumor removed during your surgery, and to follow your condition after your treatment. The purpose of this study is to determine what side effects are common or more rare from this treatment, how well the treatment has worked for you, and to track whether you develop other brain metastases.
Conditions Studied
Interventions
- RADIATION Novalis Shaped Beam Surgery
Study Locations (1)
New York
- Department of Radiation Oncology, University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-01-14 |
| Est. Completion | 2022-03-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00904553
The ClinicalTrials.gov registry entry for NCT00904553 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 415-participant average among 41 other Neoplasm Metastasis trials with a reported enrollment target (94% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neoplasm Metastasis appearing as the primary indexed condition, and to 1 intervention - of which Novalis Shaped Beam Surgery is the first listed.
NCT00904553 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00904553 about?
NCT00904553 is a clinical study titled "Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases". This study is to look more closely at the tumor removed during your surgery, and to follow your condition after your treatment. The purpose of this study is to determine what side effects are common or more rare from this treatment, how well the treatment has worked for you, and to track whether yo...
What is the current status of trial NCT00904553?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2009-01-14. Estimated completion is 2022-03-28.
What conditions does trial NCT00904553 study?
This clinical trial studies the following conditions: Neoplasm Metastasis.
What interventions are being tested in trial NCT00904553?
The interventions under investigation include: Novalis Shaped Beam Surgery (RADIATION).
Who is sponsoring clinical trial NCT00904553?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00904553 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasm Metastasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RECRUITING · Phase 3
-
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
RECRUITING · Phase 1
-
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
RECRUITING · Phase 1
-
A Study of LY4175408 in Participants With Advanced Cancer
RECRUITING · Phase 1
-
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
RECRUITING · NA
-
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.